Nuvalent Inc - Class A

Research Nuvalent Inc - Class A (NUVL) on Bullrun: market cap USD 9.76B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNUVL
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 9.76B
• Financial periodFY2025
• Net income-USD 425.40M

Valuation Snapshot

latest market cap is USD 9.76B.

About Nuvalent Inc - Class A

Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Frequently asked questions

What is Nuvalent Inc - Class A's market cap?

Nuvalent Inc - Class A's market capitalization is USD 9.76B.

What does Nuvalent Inc - Class A do?

Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.